Director's Dealing • Feb 6, 2019
Director's Dealing
Open in ViewerOpens in native device viewer
Washington, D.C. 20549
OMB APPROVAL
| OMB Number: | 3235-0287 |
|---|---|
| Estimated average burden hours | |
| per response | 0.5 |
Check this box if no longer subject to
Instruction 1(b).
Section 16. Form 4 or
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| 1. Name and Address of Reporting Person Hsiao, Ph.D. Jane H |
2. Issuer Name and Ticker or Trading Symbol OPKO Health, Inc. [OPK] |
5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ____ 10% Owner X |
||||||
|---|---|---|---|---|---|---|---|---|
| (Last) OPKO Health, Inc. 4400 Biscayne Blvd. |
(First) | (Middle) | 3. Date of Earliest Transaction (Month/Day/Year) 05/10/2017 |
Director Officer (give title below)____ Other (specify below) X Vice Chairman & CTO |
||||
| (Street) Miami FL 33137 (City) (State) (Zip) |
4. If Amendment, Date Original Filed (Month/Day/Year) 05/11/2017 |
6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person ____ Form filed by More than One Reporting Person |
| 1.Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
2A. Deemed Execution Date, if any (Month/Day/Year) |
3. Transaction Code (Instr. 8) |
(Instr. 3, 4 and 5) | 4. Securities Acquired (A) or Disposed of (D) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) |
6. Ownership Form: |
7. Nature of Indirect Beneficial |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A) or (D) |
Price | (Instr. 3 and 4) | Direct (D) or Indirect (I) (Instr. 4) |
Ownership (Instr. 4) |
|||
| Common Stock | (1) 05/10/2017 |
(1) P |
10,000 | A | \$6.94 | 4,627,404 | I | See Footnote (2) |
||
| Common Stock | (1) 05/10/2017 |
(1) P |
2,600 | A | \$6.95 | 4,630,004 | I | See Footnote (2) |
||
| Common Stock | (1) 05/10/2017 |
(1) P |
11,735 | A | \$6.97 | 4,641,739 | I | See Footnote (2) |
||
| (1) 05/10/2017 |
(1) | See |
| Common Stock | (1) 05/10/2017 |
(1) P |
5,665 | A | \$6.98 | 4,647,404 | I | Footnote (2) |
|---|---|---|---|---|---|---|---|---|
| Common Stock | (1) 05/10/2017 |
(1) P |
10,000 | A | \$6.99 | 4,657,404 | I | See Footnote (2) |
| Common Stock | 24,713,133 | D |
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security |
3. Transaction Date (Month/Day/Year) |
3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or (D) (Instr. 3, 4, and 5) |
Disposed of | 6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | (A) | (D) | Date Exercisable |
Expiration Date |
Title | Amount or Number of Shares |
Adam Logal, Attorney-In-Fact 02/05/2019
**Signature of Reporting Person Date
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.